FAFN
IRWD icon

First Affirmative Financial Network’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Affirmative Financial Network’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,930
Closed -$10.7K – 308
2025
Q2 		$10.7K Buy
14,930
+3,853
+35% +$3.02K 0.01% 279
2025
Q1 		$16.3K Buy
+11,077
New +$26.4K 0.01% 263

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

First Affirmative Financial Network's IRWD Position: Q3 2025 in Review

First Affirmative Financial Network sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2025, closing a stake of 14,930 shares — an estimated $10.7K sold.

First Affirmative Financial Network first reported a position in IRWD in Q1 2025 and held it in 2 quarters. The position peaked at $16.3K in Q1 2025. 166 funds tracked by Wall St. Rank hold IRWD as of Q3 2025.

  • First Affirmative Financial Network reported no remaining Ironwood Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • First Affirmative Financial Network sold 14,930 Ironwood Pharmaceuticals shares in Q3 2025, an estimated $10.7K.
  • First Affirmative Financial Network first reported a position in Ironwood Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • First Affirmative Financial Network's Ironwood Pharmaceuticals position peaked at $16.3K in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2025.

Based on First Affirmative Financial Network's 13F filing for Q3 2025, filed 20 Nov 2025.